Shivanand Kumatagi Reflects on His Visit to Rela Hospital
Shivanand Kumatagi, Development Officer (India) at ICCBBA, shared on LinkedIn:
”Productive Visit to Rela Hospital, Chennai
I had the opportunity to visit Rela Hospital, Chennai and it was a pleasure engaging with the Transfusion Medicine team on the importance of adopting ISBT128 standardized labeling for blood and cellular therapy products.
We discussed how the increasing use of advanced technologies—including automation, barcodes, and RFID—brings tremendous benefits but also introduces new challenges related to accuracy, interoperability, and traceability.
This is exactly where standardized, globally recognized ISBT128 play a crucial role.
They help overcome these obstacles by ensuring consistency, reducing errors, and enabling seamless communication across diverse platforms and systems.
It was encouraging to see the team’s positive response and their commitment to aligning with international standards and global best practices to enhance patient safety.
Looking forward to continuing this conversation and supporting the further strengthening of transfusion services.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026